Bleeding during neurosurgery presents one of the greatest risks for patients and surgical teams. Efficient and reliable blood management is important in the really practices to create better surgical outcomes and to save lives. SeraSeal has established itself in India as a revolutionary hemostatic agent, with a product specifically marketed to address these challenges in high-risk fields such as neurosurgery, ENT surgery, spine surgery, cardiac surgery, vascular surgery, and trauma care.
Why Controlling Blood Loss in Neurosurgery Is Critical
Neurosurgical procedures such as craniotomy, pituitary macroadenoma resections, tumor excisions, and microvascular interventions frequently involve high-risk bleeding.
Excessive blood loss can:
- Prolong surgical time
- Increase the need for blood transfusions
- Complicate recovery and raise patient risk
What Makes SeraSeal Different From Others?
SeraSeal is the world’s first primary haemostatic agent containing activated factors, composed of agar and bovine clotting proteins (factors II, VII, IX, and X). It acts as a catalyst for coagulation, which causes blood to stop within seconds, even for arterial or coagulopathic bleeds.
Key Features:
- Immediate action: Stops major hemorrhages in 1–60 seconds, depending on vessel size.
- Ready to use: No preparation or mixing needed, suitable for rapid response during emergencies.
- Preserves tissue: Does not cause burns or inflammation, leading to faster wound healing and less postoperative pain.
- Visible: Clear and colorless, allowing surgeons to see the surgical field clearly.
- Versatile Delivery: Available in syringes, sprays, foam, and trauma dressings.
SeraSeal in Neurosurgery
Common neurosurgical applications where SeraSeal makes a difference:
- Craniotomy and glioma surgeries
- Pituitary macroadenoma and meningioma resections
- Microvascular and transnasal tumor operations
In these critical procedures, SeraSeal has been shown to reduce bleeding up to 90% and reduce operative time by as much as 50%. It saves patient lives and also costs the provider less.
Bold Takeaway: During neurosurgical crises, SeraSeal can turn dangerous minutes of bleeding into a matter of seconds of rapid hemostasis, thus saving lives.
Broader Surgical Benefits
SeraSeal is effective beyond neurosurgery. Surgeons across specialties have used it safely in:
- ENT procedures: Tonsillectomy, thyroidectomy, FESS, balloon surgeries
- Cardiac surgery: Bentall procedures, valve replacements (AVR, DVR, MVR, ARR)
- Vascular surgeries: Grafting, AV fistula creation, debridement, bypasses
- Trauma care: Emergency hemorrhage control, including in military and roadside settings
- Obstetrics: Post-partum hemorrhage
- Spine surgery: Tumor removals and decompressions (C1–C2, L4–L5, D1–D7)
- Plastic surgery: Burns, flaps, and skin grafts
- Head & Neck: Commando and cervical surgeries
Clinical Evidence & Indian Approval
Clinical studies highlight SeraSeal’s superiority in reducing transfusion needs and surgical complications:
- In pediatric craniosynostosis surgery, SeraSeal reduced transfusion requirements by up to 59%.
- Recently approved for use in trauma and emergency bleeding management under Tamil Nadu’s CMCHiS (NK-48 scheme), now available in 700+ hospitals across India.
How SeraSeal Benefits Hospitals, Surgeons, and Patients
- Patients: Faster recovery, fewer transfusions, reduced risk.
- Surgeons: Reduced surgical time, better visualization, fewer complications.
- Hospitals: Lower costs, more efficient care, improved surgical outcomes.
Things you must know
- SeraSeal is an ever-innovative hemostatic agent capable of saving lives by rapidly arresting bleeding during neurosurgery and in various disciplines.
- Its use is transforming surgical care throughout India, making surgeries safer for the patients and providers alike.
For more information on SeraSeal or to order, visit our collection page or contact us directly. Together, let’s make bleeding complications a problem of the past.